Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition

Cervical cancer (CC) is the fourth most common cause of cancer-related death in women. According to international guidelines, a standard treatment for locally advanced cervical cancer (LACC) consists of exclusive concurrent chemoradiation treatment (CRT). However, chemoradioresistance and subsequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Raspaglio, Giuseppina, Buttarelli, Marianna, Filippetti, Flavia, Battaglia, Alessandra, Buzzonetti, Alexia, Scambia, Giovanni, Gallo, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511191/
https://www.ncbi.nlm.nih.gov/pubmed/34642300
http://dx.doi.org/10.1038/s41419-021-04229-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511191/
https://www.ncbi.nlm.nih.gov/pubmed/34642300
http://dx.doi.org/10.1038/s41419-021-04229-y

Ejemplares similares